Chagas Heart Disease: The Evolution of the Disease and its Complementary Exams. [PDF]
Arq Bras Cardiol, 2022 Cunha CLPD.
europepmc +1 more source
Defibrillation Threshold in Patients with Chronic Chagas' Heart Disease: Are There Benefits or not Worth the Risk? [PDF]
Arq Bras Cardiol, 2022 Teixeira RA.
europepmc +1 more source
Noninvasive Cardiac Radioablation for Chagas Heart Disease. [PDF]
Arq Bras Cardiol, 2023 Wiener PC +4 more
europepmc +1 more source
Evaluation of Various Pathophysiological Pathways in the Prognosis of Heart Failure with Reduced Ejection Fraction: Seeing Beyond the Heart. [PDF]
Arq Bras Cardiol, 2022 Barbosa-Ferreira JM, Oliveira AA.
europepmc +1 more source
T1 Mapping in Heart Failure: Prognostic Implications. [PDF]
Arq Bras Cardiol, 2021 Moharem-Elgamal S.
europepmc +1 more source
Diagnostic and Prognostic Importance of Functional Capacity in the Different Evolutionary Forms of Chagas Disease. [PDF]
Arq Bras Cardiol, 2021 Barbosa-Ferreira JM +2 more
europepmc +1 more source
Cardiac and digestive forms of chronic Chagas disease in Brazilian social welfare, 2004-2016. [PDF]
Rev Bras Med Trab, 2023 Limongi JE +3 more
europepmc +1 more source
Does Galectin-3 (Myocardial Fibrosis Biomarker) Predict Progression in Chagas Disease? [PDF]
Arq Bras Cardiol, 2021 Pedrosa RC.
europepmc +1 more source
Ativação adrenérgica intramiocárdica na cardiomiopatia chagásica e doença arterial coronariana
Arquivos Brasileiros de Cardiologia, 2011 FUNDAMENTO: A norepinefrina miocárdica está alterada na disfunção ventricular esquerda. Em pacientes com cardiomiopatia chagásica (CC), essa questão ainda não foi discutida.
Luciano Nastari +7 more
doaj
Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction. [PDF]
Arq Bras Cardiol, 2022 Tassi EM +4 more
europepmc +1 more source